Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Lucid Diagnostics Inc. (LUCD) vs MaxCyte, Inc. (MXCT)

Lucid Diagnostics Inc. and MaxCyte, Inc. are both Medical Devices companies. Lucid Diagnostics Inc. is the larger, with a market value of $170.3M against $122.8M — 1.4× the size. Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against −13.2%. MaxCyte, Inc. has the higher net margin (−114.8% vs −1,193.9%) and the higher return on invested capital (−49.2% vs −3,096.5%). Across the 17 metrics below, MaxCyte, Inc. leads on 13 and Lucid Diagnostics Inc. on 4.

Valuation

Metric LUCD MXCT Medical Devices median
P/E n/m n/m 22.18
P/S 27.91 4.03 2.70
P/B 13.91 0.79 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 26.10 1.23 2.38
Earnings yield (56.63%) (28.21%) (8.22%)
Free cash flow yield (31.04%) (18.92%) (7.80%)

Profitability

Metric LUCD MXCT Medical Devices median
Gross margin (21.69%) 79.23% 56.01%
Operating margin (930.84%) (134.59%) (15.03%)
Net margin (1,193.87%) (114.77%) (20.40%)
Free cash flow margin (866.56%) (76.14%) (7.24%)
Return on equity 364.89% (20.39%) (15.32%)
Return on assets (167.51%) (17.62%) (19.72%)
Return on invested capital (3,096.53%) (49.23%) (10.33%)

Growth

Metric LUCD MXCT Medical Devices median
Revenue growth (TTM) 24.89% (13.15%) 8.80%
EPS growth (last fiscal year) 34.29% (7.69%) —
Revenue growth, 5-year CAGR — 4.76% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LUCD MXCT Medical Devices median
Debt to equity 2.15 0.00 0.07
Current ratio 1.33 12.26 2.50
Net debt to EBITDA 0.22 2.21 0.49

Dividend

Metric LUCD MXCT Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric LUCD MXCT Medical Devices median
Market cap 170.32m 122.82m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack